Severe hepatic steatosis contributes to liver dysfunction in non‐obese patients with insulin‐resistant diabetes mellitus after hematopoietic stem cell transplantation
Pediatrics International · 2025-01 · 67 (1)
DOI: 10.1111/ped.70192 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pediatrics International, online erschienen am 22.09.2025. Verfasst von Haruki Yamano und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Developmental Biology, Institute of Science Tokyo School of Medicine, Bunkyo-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Insulin Resistance, Fatty Liver, Diabetes Mellitus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Heart-link Working Project.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Non‐obese survivors of childhood hematopoietic stem cell transplantation (HSCT) often exhibit severe insulin resistance and mild hepatic dysfunction. Although the exact pathophysiology remains unclear, one possible explanation is the increasingly recognized condition known as HSCT‐associated partial lipodystrophy. In lipodystrophy, hepatic dysfunction is characterized by fibrosis and severe steatosis, resembling nonalcoholic steatohepatitis. Accordingly, detailed hepatic assessment would improve our overall understanding of the condition. This study aimed to evaluate hepatic dysfunction using a non‐invasive method (FibroScan) in patients who developed glucose intolerance post‐HSCT.
Methods
Fourteen non‐obese childhood HSCT survivors from two institutions underwent FibroScan. They were classified according to the presence or absence of diabetes mellitus (DM) with insulin resistance (HOMA‐IR >2.5 or insulin therapy >1.5 U/kg/day). FibroScan provided controlled attenuation parameter (CAP) for hepatic steatosis and liver stiffness measurements (LSM) for fibrosis. Serum hepatic fibrosis markers (collagen type IV and hyaluronic acid) were also measured.
Results
Seven patients developed insulin‐resistant DM while seven had normal glucose/lipid metabolism. All DM patients showed “Dunnigan”‐type subcutaneous fat distribution. CAP values were higher in the DM group [307 (261.0–343.5) vs. 237 (216.5–271.0), p = 0.041], as were LSM scores [6.7 (5.9–9.9) vs. 4.1 (3.5–4.7), p = 0.007], indicating more severe steatosis and increased liver stiffness. However, serum hepatic fibrosis markers did not differ significantly. Conslusions Non‐obese HSCT survivors with insulin‐resistant DM exhibited severe hepatic fat accumulation and progression of liver fibrosis attributable to lipodystrophy. FibroScan may have potential utility for monitoring liver health in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics and Developmental Biology, Institute of Science Tokyo School of Medicine, Bunkyo-ku, Tokyo, Japan.
- Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, Minami-ku, Hiroshima, Japan.
- Clinical Laboratory, Institute of Science Tokyo Hospital, Bunkyo-ku, Tokyo, Japan.
- Department of Gastroenterology and Hepatology, Institute of Science Tokyo School of Medicine, Bunkyo-ku, Tokyo, Japan.
- Division of Endocrinology and Metabolism, National Center for Child Health and Development (NCCHD), Setagaya-ku, Tokyo, Japan.
ORCID-Profile: Haruki Yamano, Takeshi Isoda, Takahiro Kamiya, Satoshi Okada, Kei Takasawa, Kenichi Kashimada
Förderung
- Heart-link Working Project
Zitieren
APA
Yamano, H., Kagawa, R., Saito, Y., Iemura, R., Adachi, E., Maki, G., Yamauchi, T., Nakagawa, R., Sutani, A., Takishima, S., Kitahata, F., Murakawa, M., Isoda, T., Kamiya, T., Okada, S., Morio, T., Takasawa, K., & Kashimada, K. (2025). Severe hepatic steatosis contributes to liver dysfunction in non‐obese patients with insulin‐resistant diabetes mellitus after hematopoietic stem cell transplantation. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70192
Vancouver
Yamano H, Kagawa R, Saito Y, Iemura R, Adachi E, Maki G, et al. Severe hepatic steatosis contributes to liver dysfunction in non‐obese patients with insulin‐resistant diabetes mellitus after hematopoietic stem cell transplantation. Pediatrics International. 2025;67(1). doi:10.1111/ped.70192
BibTeX
@article{Yamano2025,
author = {Yamano, Haruki and Kagawa, Reiko and Saito, Yoko and Iemura, Ryosei and Adachi, Eriko and Maki, Gau and Yamauchi, Takeru and Nakagawa, Ryuichi and Sutani, Akito and Takishima, Shigeru and Kitahata, Fukiko and Murakawa, Miyako and Isoda, Takeshi and Kamiya, Takahiro and Okada, Satoshi and Morio, Tomohiro and Takasawa, Kei and Kashimada, Kenichi},
title = {Severe hepatic steatosis contributes to liver dysfunction in non‐obese patients with insulin‐resistant diabetes mellitus after hematopoietic stem cell transplantation},
journal = {Pediatrics International},
year = {2025},
volume = {67},
number = {1},
doi = {10.1111/ped.70192}
}
EUVIMED